NL-OMON54017招募中2 期
DEBuT-LRP study: Intravascular Identification and Drug-Eluting Balloon Treatment of Vulnerable Lipid-Rich Plaques - DEBuT-LRP
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •1. Patient has an acute coronary syndrome without ST-segment elevation on the
- •ECG (NSTE-ACS), includingnon-ST-elevation myocardial infarction and unstable
- •angina pectoris.
- •2. An invasive revascularization strategy for NSTE-ACS with PCI is chosen.
排除标准
- •Angiographic exclusion criteria:
- •1. Previous coronary artery bypass-grafting;
- •2. A chronic total occlusion is present;
- •3. Too many (complex) coronary lesions requiring staged PCI procedure(s);
- •4. Procedural complication of the index PCI;
- •Clinical exclusion criteria:
- •5. Unstable patients (the presence of cardiogenic shock, need for intubation,
- •need for inotropes);
- •6. Patients with ST-segment elevations on the ECG requiring immediate primary
- •7. Body weight > 250 kg;
- •8. Known renal insufficiency (estimated Glomerular Filtration Rate [eGFR] <30
- •mL/min/1.73m2 or subject on dialysis);
- •9. Hypersensitivity or allergy to contrast with inability to properly
- •pre-hydrate;
- •10. Presence of a comorbid condition with a life expectancy of less than one
- •11. Participation in another trial;
- •12. Subject is belonging to a vulnerable population (per investigator*s
- •judgment, e.g., subordinate hospital staff) or is unable to read or write.
研究者
相似试验
撤回
2 期
DEBuT-LRP study: Non-invasive and Intravascular Identification and Drug-Eluting Balloon Treatment of Vulnerable Lipid-Rich Plaquesmyocardial infarction10011082NL-OMON49521Academisch Medisch Centrum40
招募中
1 期
Intradermal LPS to study vascular responsesImmunological/cardiovascular conditionsCTIS2024-512377-27-00Centre for Human Drug Research32
进行中（未招募）
不适用
Evaluation study of the peripheral infusion leakage in infants and children: ivWatchpost surgical childrenJPRN-jRCTs062210017Kanazawa Tomoyuki100
招募中
不适用
The study of biomarkers for intractable vascular anomalies and associated with pharmacological action of sirolimusVascular anomaliesJPRN-UMIN000029173Gifu University50
进行中（未招募）
1 期
Clinical trial of a single dose of treprostinil injected as a depot under the skin to investigate the effect on the digital blood flow and safety in patients with Raynaud’s Phenomenon due to Systemic SclerosisRaynaud’s phenomenon secondary to systemic sclerosisMedDRA version: 20.0Level: PTClassification code 10037912Term: Raynaud's phenomenonSystem Organ Class: 10047065 - Vascular disordersEUCTR2019-002444-24-GBCamurus AB12